Related Experiment Video
Updated: Jun 10, 2026
10:16
Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
Successes and failures: Worldwide vaccine development and application
1Global Solutions for Infectious Diseases, 830 Dubuque Avenue, South San Francisco, CA 94080, USA. dfrancis@gsid.org
Summary
Vaccines have saved countless lives and prevented immense suffering globally. However, missed opportunities highlight the need for continued innovation in vaccine development to combat infectious diseases.
Area of Science:
- Global Health
- Immunology
- Vaccinology
Background:
- Vaccines have profoundly impacted global health, saving lives and reducing suffering.
- Despite successes, historical and current vaccine programs present missed opportunities.
Purpose of the Study:
- To provide a comprehensive worldwide overview of vaccines.
- To examine both the successes and failures in vaccine research, development, and application.
- To explore future potential for preventing infectious diseases.
Main Methods:
- Literature review
- Historical analysis
- Global health impact assessment
Main Results:
- Vaccines have demonstrated significant public health benefits.
- Certain vaccine development and implementation strategies have faced challenges and limitations.
- Analysis reveals areas for improvement in global vaccine strategies.
Conclusions:
- Continued research and development are crucial for future vaccine advancements.
- Addressing past failures can optimize future vaccine applications.
- Optimism exists for vaccines to further reduce the burden of infectious diseases worldwide.
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:51Vaccinations
Overview
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:24Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...